Towards a Genetic Atlas of the Plain People in Western Pennsylvania: Improving Diagnosis, Access, and Health Outcomes - Abstract The Plain people (Amish and Mennonites) of western Pennsylvania (wPA) represent a rapidly growing, underserved population in the U.S. While genetic studies among Plain communities have significantly contributed to the discovery of new genetic disorders, expanded the phenotypes of others, and provided valuable insights into treatment strategies, these populations remain underrepresented in genomic studies and databases. These communities face barriers to healthcare due to lack of modern transportation, higher education, health insurance, and typically low income with large family sizes. Despite the high density of Amish people in wPA, the spectrum of genetic disorders prevalent among them is poorly studied compared to other Plain communities. Given that the Amish are the fastest-growing population in the U.S., it is critical to recognize the genetic conditions affecting them to improve healthcare delivery. In this study, we aim to develop a comprehensive understanding of the unique population genetics of the wPA Plain communities. In 2016, we established the Plain Community Translational Medicine Program at UPMC Children’s Hospital of Pittsburgh to bridge the gap in healthcare and pioneer research opportunities tailored to the needs of the Plain people in wPA. Our established relationships with local families and community leaders have facilitated access to genetic services and led to multiple research studies, revealing both known and novel genetic disorders. The long-term goal of this proposal is to create a comprehensive genetic atlas of prevalent disorders in wPA Plain communities. This resource will inform precision medicine, enhance early detection, improve healthcare access, and reduce costs through targeted screening and healthcare policies. Through this study, we will recruit families for genome sequencing and apply machine learning and bioinformatics tools for diagnosis. We will also analyze existing and newly obtained exome and genome sequencing data to assess the prevalence of ~1,300 known gene variants in Plain people, many of which are associated with genetic disorders seen in different Plain communities in the U.S. Additionally, we will investigate rare gene variants with pathogenic potential, particularly those associated with autosomal recessive disorders and previously unknown in Plain people (Aim 1). Furthermore, we will study the natural history of a novel GUCY2C variant in a Mennonite family with 25 affected individuals, who experience variable severity of chronic diarrhea, bowel dilatation and tapering enteroplasty surgery in some. We aim to identify factors contributing to this variability, including genetic, environmental, sex, and age influences (Aim 2). Completion of these aims will enhance our understanding of the breadth of genetic disorders in wPA Plain communities, underscore the importance of equitable access to genomic testing in underserved population, and ultimately enable us to provide better medical care in alignment with NIH's mission.